The 'What, Why, Where and How' of Delivering a Drug.
作者信息
Mukherjee Kusumika
机构信息
Trends in Pharmacological Sciences, Cell Press, 50 Hampshire Street, Cambridge, MA 02139, USA.
出版信息
Trends Pharmacol Sci. 2020 Oct;41(10):679-680. doi: 10.1016/j.tips.2020.08.007.
Abstract
摘要
相似文献
1
The 'What, Why, Where and How' of Delivering a Drug.给药的“是什么、为什么、在哪里以及如何做”
Trends Pharmacol Sci. 2020 Oct;41(10):679-680. doi: 10.1016/j.tips.2020.08.007.
2
Dissociating 'what' and 'how' in visual form agnosia: a computational investigation.视觉形式失认症中“什么”与“如何”的分离：一项计算研究。
Neuropsychologia. 2002;40(2):187-204. doi: 10.1016/s0028-3932(01)00072-0.
3
High time to unpack the 'how' and 'why' of adherence interventions.是时候剖析依从性干预措施的“方式”和“原因”了。
AIDS. 2016 May 15;30(8):1301-4. doi: 10.1097/QAD.0000000000001071.
4
Interdisciplinary research in public health: the 'why' and the 'how'.公共卫生领域的跨学科研究：“为何”与“如何”。
J Epidemiol Community Health. 2019 Dec;73(12):1061-1062. doi: 10.1136/jech-2019-212511. Epub 2019 Oct 8.
5
Understanding the 'how' and 'why' of our choices.理解我们选择的“方式”和“原因”。
Nurse Res. 2008;16(1):3.
6
More important than 'what' or 'how' is the 'why' behind individual work performance.个人工作表现背后的“为什么”比“做什么”或“怎么做”更重要。
Manage Rev. 1984 Oct;73(10):69-72.
7
Early palliative care: moving from 'why' to 'how'.早期姑息治疗：从“为何”转向“如何”。
Oncology (Williston Park). 2013 Jan 15;27(1).
8
9
The early estimation of circulating drug metabolites in humans.在人类中循环药物代谢物的早期估算。
Expert Opin Drug Metab Toxicol. 2012 Aug;8(8):985-97. doi: 10.1517/17425255.2012.693159. Epub 2012 Jun 10.
10
Reducing antibiotics for respiratory tract symptoms in primary care: 'why' only sore throat, 'how' about coughing?减少基层医疗中用于呼吸道症状的抗生素使用：为何仅针对喉咙痛，那咳嗽该如何处理？
Br J Gen Pract. 1999 May;49(442):400-1.
本文引用的文献
1
Tackling TAMs for Cancer Immunotherapy: It's Nano Time.针对癌症免疫疗法的肿瘤相关巨噬细胞：是时候采用纳米技术了。
Trends Pharmacol Sci. 2020 Oct;41(10):701-714. doi: 10.1016/j.tips.2020.08.003.
2
Nanoformulation of BRD4-Degrading PROTAC: Improving Druggability To Target the 'Undruggable' MYC in Pancreatic Cancer.BRD4 降解 PROTAC 的纳米制剂：提高药物靶向性以针对胰腺癌中的“不可成药”MYC。
Trends Pharmacol Sci. 2020 Oct;41(10):684-686. doi: 10.1016/j.tips.2020.08.008. Epub 2020 Sep 4.
3
Paving the Road for RNA Therapeutics.为 RNA 治疗学铺平道路。
Trends Pharmacol Sci. 2020 Oct;41(10):755-775. doi: 10.1016/j.tips.2020.08.004. Epub 2020 Sep 3.
4
Inhaled RNA Therapy: From Promise to Reality.吸入式 RNA 疗法：从承诺到现实。
Trends Pharmacol Sci. 2020 Oct;41(10):715-729. doi: 10.1016/j.tips.2020.08.002. Epub 2020 Sep 4.
5
Accessing Intracellular Targets through Nanocarrier-Mediated Cytosolic Protein Delivery.通过纳米载体介导的细胞质蛋白递送来靶向细胞内靶标。
Trends Pharmacol Sci. 2020 Oct;41(10):743-754. doi: 10.1016/j.tips.2020.08.005. Epub 2020 Sep 2.
6
Amphiphilic Polyacrylamide Excipients Lead to a Record-Breaking Fast-Acting Insulin.两亲性聚丙烯酰胺赋形剂造就创纪录的速效胰岛素。
Trends Pharmacol Sci. 2020 Oct;41(10):681-684. doi: 10.1016/j.tips.2020.08.006. Epub 2020 Sep 2.
7
Cancer Nanomedicines in an Evolving Oncology Landscape.癌症纳米药物在不断发展的肿瘤学领域中的应用。
Trends Pharmacol Sci. 2020 Oct;41(10):730-742. doi: 10.1016/j.tips.2020.08.001. Epub 2020 Aug 29.
8
Fluorescein Isothiocyanate Chitosan Nanoparticles in Oral Drug Delivery Studies.荧光素异硫氰酸酯壳聚糖纳米粒在口服给药研究中的应用。
Trends Pharmacol Sci. 2020 Oct;41(10):686-689. doi: 10.1016/j.tips.2020.07.005. Epub 2020 Aug 26.
9
Modulating the Blood-Testis Barrier Towards Increasing Drug Delivery.调控血睾屏障以增加药物递送。
Trends Pharmacol Sci. 2020 Oct;41(10):690-700. doi: 10.1016/j.tips.2020.07.002. Epub 2020 Aug 10.
10
Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' for the treatment of pancreatic cancer.针对“不可成药”靶点的 PROteolysis TArgeting Chimera 的纳米制剂，用于治疗胰腺癌。
Nanomedicine (Lond). 2020 Aug;15(18):1761-1777. doi: 10.2217/nnm-2020-0156. Epub 2020 Jul 23.
Zotero 插件